Zhejiang Huakang Pharmaceutical Co., Ltd, which specialises in the manufacture of polyols and starch sugar used in the food ingredient industry, has kicked off the subscription exercise for its initial public offering (IPO) in Shanghai looking to raise 1.5 billion yuan ($233 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
